XBiotech Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
XBiotech Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • XBiotech Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $379K, a 58.5% decline year-over-year.
  • XBiotech Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.4M, a 36.5% decline year-over-year.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.26M, a 35.6% decline from 2022.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.06M, a 13.4% increase from 2021.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.46M, a 64.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.26M -$1.8M -35.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $5.06M +$599K +13.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $4.46M -$8.12M -64.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $12.6M +$9.22M +275% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $3.36M +$1.7M +102% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $1.66M -$816K -33% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 $2.48M -$3.1M -55.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $5.57M +$1.17M +26.5% Jan 1, 2016 Dec 31, 2016 10-K/A 2019-03-15
2015 $4.41M -$2.61M -37.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $7.02M +$6.28M +850% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $739K Jan 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.